Generics/Research
Evaluation of pharmaceutical equivalency of manufactured generic drugs in UAE
Generic medicines are pharmaceutical products manufactured to be equivalent to the brand or innovator drug products. They represent the majority of worldwide prescribed medicines; therefore, their quality is critical to ensure equivalent therapeutic outcomes
New insights into the amount of R & D for new uses of generic drugs
Generic drugs are considered indispensable to healthcare systems because they are substantially cheaper than original versions of the drugs. These drugs have become common place, within healthcare delivery, because of the anticipated financial benefits [1].
Pricing and reimbursement of medicines in Canada
Canada is a wealthy country with gross domestic product (GDP) per capita of US$43,258 in 2020. It ranks 16th in the United Nations’ Human Development Index and is one of the most multicultural countries in the world. Canada’s population of more than 38 million includes a significant indigenous population. Its huge land mass means it is very sparsely populated outside urban areas. Authors from Canada and Brazil discuss the pharmaceutical pricing and reimbursement policies in Canada [1].
Medicines pricing conditions in Italy and Brazil: comparison of regulations
In the context of the National Health Services (NHS), the gearing that moves the health services comprises a legal framework, permeated by technical and economic parameters.
Relevance of NTI to the treatment of epilepsy
In a mini review, author a Roy G Beran discusses what is the relevance of a narrow therapeutic index (NTI) to the treatment of epilepsy [1].
What is the meaning of a narrow therapeutic index?
What is the meaning of a narrow therapeutic index (NTI) is a topic explained by author Roy G Beran, in a mini review [1].
Consequences of generics being favoured by healthcare providers
Generics are favoured by healthcare providers due to a variety pf reasons, according to author Roy G Beran [1].
What is meant by a generic medication and generic equivalence?
Author Professor Roy G Beran, in a mini review, explains what generics are and what is meant by generic equivalence [1].
The cost of developing drugs and use of generics
In a mini review, author Professor Roy G Beran explains how generics can be produced at a much lower cost than originator drugs [1].
Re-evaluation of the use of generics, especially when treating conditions such as epilepsy
Regulatory bioequivalence rules for generics are well established and recognized. However, proving bioequivalence may not always be so easy, especially with drugs with a narrow therapeutic index (NTI) [1].
